Health Trials

Myeloprolipherative Neoplsm

2

Review clinical trials related to Myeloprolipherative Neoplsm. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched Donor

Optimization of bendamustine-containg graft-versus-host disease (GVHD) prophylaxis to reduce the incidence of secondary haemophagocytic lymphohistiocytosis and GVHD

Participants needed: 60
Trial details
Phase: Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: St. Petersburg State Pavlov Medical UniversityUpdated: Nov 20, 2025Locations: 1
Eligibility criteria

Patients with indication for allogeneic hematopoietic stem cell transplantation [+2]

Patients with indication for allogeneic hematopoietic stem cell transplantation [+2]

Read more
Status: Recruiting

Vitamin A and D Supplementation in Allogeneic HCT

The therapy under investigation is the addition of 300 000 IU of vitamin A and 100 000 IU of vitamin D before conditioning. The study will include patients with malignant diseases in hematologic response with indications for allogeneic transplantation with matched related or matched unrelated donor.

Participants needed: 220
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: St. Petersburg State Pavlov Medical UniversityUpdated: Jul 31, 2024Locations: 1
Eligibility criteria

Diagnosis: acute myeloid leukemia, acute lymphoblastic leukemia, myelodysplastic... [+4]

- Severe organ failure: creatinine more than 2 norms; ALT, AST more than 5 norms... [+10]

Read more